Investigating Rare Kidney Diseases Through Genetic Studies, -Omic Approaches & Epidemiology
Time: 8:31 am
day: Workshop A
Details:
- Powering up the rare kidney disease drug development by leveraging genetic and -omic patient profiles from natural history of disease studies in FSGS, MCD, MGN, and IgAN to identify and validate therapeutic targets
- Mapping models and response profiles in models to rare and genetic kidney disease patients to predict mechanistic markers of patient response
- Matching gene profiles to biomarkers and predictors of response to therapies to strategize patient selection approaches
